AVXL - Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Anavex Life Sciences Corp. (AVXL) | Benzinga
LOS ANGELES, March 29, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming May 13, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL) securities between February 1, 2022 and January 1, 2024, inclusive (the "Class Period").
If you suffered a loss on your Anavex investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at www.glancylaw.com/cases/Anavex-Life-Sciences-Corp-1/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com to learn more about your rights.
On January 2, 2024, Anavex announced results from a Phase 2/3 EXCELLENCE Clinical Study in Pediatric Rett Syndrome, reporting that the "co-primary endpoint . . . was not ...
AVXL)>Full story available on Benzinga.com